NYSCRF has committed to invest a sum of $400 million in Hamilton Lane NY Israel Fund II, which will target Israel-focused funds and co-investments primarily in the technology and healthcare/life sciences sectors.
It has also committed €300 million ($305.6 million) to Knickerbocker Co-Investment Partners, a co-investment vehicle by CVC Capital Partners, which will invest in select, high conviction opportunities alongside the firm’s European/Americas and Asian funds.